New Leukemia Drug Found Effective

Wednesday, 24 Jul 2013 12:29 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Roche's experimental leukemia drug known as GA101 delayed disease progression in people with one of the most common forms of blood cancer longer than its top-seller Rituxan, the Swiss drugmaker said on Wednesday.
Roche is hoping GA101 will help fend off cheaper competition for Rituxan, which loses patent protection in Europe later this year, threatening a blockbuster product with nearly $7 billion in annual sales.
A late stage study showed GA101, or obinutuzumab, used in combination with chemotherapy, helped people with a particular form of leukemia live longer without their disease worsening when compared with Rituxan which is also known as MabThera.
The drugs were given in conjunction with the commonly used chemotherapy chlorambucil to previously untreated patients with chronic lymphocytic leukemia (CLL) who also had other health problems, such as heart disease.
Roche said specific sugar molecules in GA101 were modified to change its interaction with the body's immune cells, creating a unique antibody designed to engage the patient's own immune system to help attack the cancerous cells.
Roche said final data from the study would be submitted to the American Society of Hematology's annual meeting in December.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Did Joan Rivers Have Cancer When She Died?

Wednesday, 17 Sep 2014 13:50 PM

The cardiac arrest leading to Joan Rivers' death occurred when her personal physician began a biopsy after seeing a "sus . . .

First Volunteer Gets Experimental Ebola Vaccine

Wednesday, 17 Sep 2014 12:59 PM

The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline rece . . .

Doctor Admits Profiting by Giving Patients Unneeded Chemo

Wednesday, 17 Sep 2014 12:56 PM

A Detroit-area cancer doctor accused of putting people through unnecessary treatments and then billing insurers for mill . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved